Tuberculosis vaccine shows superior immune response protection in nonhuman primates when compared to existing BCG vaccine A ...

Tuberculosis remains the number one cause of infectious mortality worldwide A candidate mRNA vaccine that boosts immunity ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

Taking a step further to achieve total eradication of tuberculosis, the Rajasthan government on Tuesday launched the Adult BCG vaccination campaign.

As donor support dwindles ahead of 2029, Gavi, the Vaccine Alliance has formally reminded the government to fulfill its ...

A phase 2b trial has found that the vaccine has an overall protective efficacy of 50% three years after immunisation, an advance on the current BCG vaccine which is not very effective and ...

It is important that the Global South and Global North continue to work together, finding solutions to these diseases that ...

Nigeria is facing a critical funding shortfall in its efforts to combat tuberculosis (TB), with an estimated 80,000 expected ...

Dementia risk factors range from mental health to diet. Ask your doctor about them to help you slow down or prevent the onset ...

Gujarat has achieved 95.95 per cent vaccination coverage under the Universal Immunisation Programme (UIP) as part of the ...